Navigating Treatment with BTK Inhibitors
Friday, August 6, 2021 at 3:00 PM ET
Join us for a 1-hour online educational session led by Dr. Matthew Davids, Associate Professor of Medicine, Harvard Medical School, Associate Director, Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute, live on Friday, August 6, at 3:00 PM ET. This educational module is the first in a series, specifically designed to help patients and caregivers understand the available treatment options for CLL across the continuum of care, learn about the details of BTK-inhibitor treatments, and confidently talk with their doctors and other clinicians to align their goals and priorities for care. Send your questions to the expert panel.